Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Recruiting now · Not applicable
Conditions studied: Head and Neck Squamous Cell Carcinoma HNSCC
In brief
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.
Key facts
- Study ID
- NCT07190755
- Run by
- Centre Henri Becquerel
- People needed
- 192
- Starts
- 2025-10-15
- Expected to finish
- 2030-06-01
- Last updated by the study team
- 2025-12-30
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient aged over 18 and under 75 years WHO score < 2,
- Treated for localised heand and neck cancer of the squamous cell carcinoma type for which curative treatment has been chosen and receiving radiotherapy or radio-chemotherapy exclusively or as an adjuvant with the aim of cure
- Having signed the informed consent form,
- Affiliated with or beneficiary of a social protection scheme,
- Access to a smartphone or the internet,
You may not qualify if…
- History of other neoplastic disease less than 2 years ago or progressive disease,
- History of ENT radiotherapy,
- Pregnant or breastfeeding women,
- Protected adults (under guardianship, curatorship or judicial protection),
- Patients participating in a therapeutic study,
- Patients unable to understand the study for any reason or to comply with the constraints of the trial (language, psychological or geographical issues, etc.), patients with blindness preventing the use of the medical telemonitoring solution in oncology.
Where it is running
- Centre Henri Becquerel — Rouen, France (enrolling)
- Institut de Cancérologie de Lorraine — Vandœuvre-lès-Nancy, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.